| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42.7M | -1.6% | +2073.5% |
| R&D Expense | $1.3M | +36.3% | +14.4% |
| SG&A Expense | $11.6M | +8.0% | -0.3% |
| Operating Income | -$3.7M | -163.7% | +84.6% |
| Income Tax | $0 | — | — |
| Net Income | -$8.0M | -471.0% | +62.4% |
| EPS (Basic) | -$0.03 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.6M | +26.8% | -67.5% |
| Accounts Receivable | $7.7M | -29.8% | +448.7% |
| Inventory | $21.9M | +29.4% | +274.8% |
| Current Assets | $136.7M | -19.8% | -42.2% |
| Total Assets | $685.2M | -2.4% | +13.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.4M | — | — |
| Capital Expenditures | $18.9M | — | — |
| Investing Cash Flow | -$217.4M | — | — |
| Financing Cash Flow | $100.1M | — | — |
| Free Cash Flow | -$52.3M | — | — |
| +66.7% |
| EPS (Diluted) | -$0.03 | -400.0% | +66.7% |
| $71.7M |
| -2.1% |
| +149.9% |
| Long-term Debt | $164.5M | -1.8% | +145.6% |
| Total Liabilities | $210.4M | -5.4% | +112.4% |
| Stockholders' Equity | $468.9M | -1.1% | -7.1% |